Home › GeneOne Life Science And Inovio Pharmaceuticals To Collaborate On Zika Virus Vaccine Development
 

Keywords :   


GeneOne Life Science And Inovio Pharmaceuticals To Collaborate On Zika Virus Vaccine Development

2016-01-25 04:31:25| drugdiscoveryonline News Articles

GeneOne Life Science (KSE:011000) today announced the initiation of a collaborative research program with Inovio Pharmaceuticals (NASDAQ:INO) to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection.

Tags: life development science virus

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05TSCRA Disaster Relief Fund distributes $900,000 in financial assistance
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
More »